Weekly Somapacitan is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial

CONTEXT: Somapacitan, a once-weekly reversible albumin-binding GH derivative, is evaluated in children with GH deficiency (GHD). OBJECTIVE: To demonstrate efficacy and safety of somapacitan vs daily GH. METHODS: REAL4 is a randomised, multinational, open-labeled, active-controlled parallel group pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Bradley S, Blair, Joanne C, Rasmussen, Michael Højby, Maniatis, Aristides, Kildemoes, Rasmus Juul, Mori, Jun, Polak, Michel, Bang, Rikke Beck, Böttcher, Volker, Stagi, Stefano, Horikawa, Reiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693810/
https://www.ncbi.nlm.nih.gov/pubmed/36062966
http://dx.doi.org/10.1210/clinem/dgac513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693810/
https://www.ncbi.nlm.nih.gov/pubmed/36062966
http://dx.doi.org/10.1210/clinem/dgac513

Ejemplares similares